Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2017 Aug 16;3(9):e204. doi: 10.1097/TXD.0000000000000720

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2017 The Author(s). Transplantation Direct. Published by Wolters Kluwer Health, Inc.

This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.

PMC Copyright notice

uANG and uKIM1 are not predictive of allograft function. A, Multiple linear regression analysis (standard least squares model) between eGFR 3 months after transplantation and parameters associated with eGFR at month 3 with P < 0.2 in univariate analysis: donor age, DGF (no) extended criteria donor (no), biopsy proven acute rejection (no), uANG and CIT. Living donors excluded (n = 186) Estimate values give the estimate of the model coefficients for each term. The t ratio is the ratio of the estimate to its standard error, and tests whether the true value of the parameter is zero. B, Multiple linear regression analysis (standard least squares model) between eGFR 12 months after transplantation and parameters associated with eGFR at month 12 with P < 0.2 in univariate analysis: donor age, biopsy proven acute rejection (no), DGF (no), uANG, extended criteria donor (no), and uKIM1. Living donors excluded (n = 147). C, Multiple linear regression analysis (standard least squares model) between eGFR 3 months after transplantation and biological parameters associated with eGFR at month 3 with P < 0.2 in univariate analysis: plasma creatinine, de novo DSAs, preformed donor serum antibodies and uANG. Living donors excluded (n = 186). D, Multiple linear regression analysis (standard least squares model) between eGFR 12 months after transplantation and biological parameters associated with eGFR at month 12 with P < 0.2 in univariate analysis: plasma creatinine, de novo DSAs, preformed donor serum antibodies and uANG. Living donors excluded (n = 152).